Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Conferences

Harry Glorikian to Speak on Personalized Medicine: A Changing Landscape during the conference AT THE CROSSROADS OF DIAGNOSTICS AND THERAPEUTICS

Topic:

The Changing Trends in Molecular Medicine
The conference is designed to provide unique value for buy-side entities interested in (or already active in) the dynamic and evolving diagnostics space. The event will include presentations from corporate executives on the changing environment for molecular diagnostics, the balance between routine and esoteric testing, regulatory and commercial strategy for companion diagnostics, reimbursement, top M&A picks in the industry and more.

Agenda:

• 8:00-8:30 AM - Registration
• 8:30-8:40 AM - Welcome, Patrick J. Gallagher/ Jonathan B. Fassberg
• 8:40-9:15 AM - Keynote Address and Discussion, Rina Wolf - The Changing Parameters for Molecular Diagnostics: Are There New Barriers for Entry?
• 9:15-9:45 AM - Laboratory Industry Address and Discussion, Mohan Chellani
• 9:45-10:15 AM - Academic Address and Discussion, John V. Heymach, MD Anderson, TX - Biomarkers and Clinical Care Today and in the Future
• 10:15-10:45 AM - Pharma-Biotech Address and Discussion, John DeYoung, Pfizer Inc. - What we are looking for?
• 11:05-11:15 AM - Investment Industry Panel
• 11:15-12:00 PM - New Frontiers in MDX, Presentations and Discussions:
- Personalized Medicine: A Changing Landscape, Harry Glorikian, Scientia Advisors
- Point of Care in West and in Asia:Shifting Sands of Care, Randy Milby/Ning Wang, MW Bridges
- New Frontiers

• 12:00-1:00 PM - Lunch and General MDX Panel

Value Add:

• Access to thought leaders and end users of current diagnostic development
• Insight into current trends and constraints in diagnostic strategy and implementation
• One-on-one sessions with diagnostic industry leaders
• Participation in the BDR.Wiktive Diagnostics market, a real-time virtual trading forum for leading-edge innovation in the diagnostics arena